Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice

The recent Ebola virus (EBOV) epidemic in West Africa demonstrates the potential for a significant public health burden caused by filoviral infections. No vaccine or antiviral is currently FDA approved. To expand the vaccine options potentially available, we assessed protection conferred by an EBOV...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Virol
Autors principals: Lennemann, Nicholas J., Herbert, Andrew S., Brouillette, Rachel, Rhein, Bethany, Bakken, Russell A., Perschbacher, Katherine J., Cooney, Ashley L., Miller-Hunt, Catherine L., Ten Eyck, Patrick, Biggins, Julia, Olinger, Gene, Dye, John M., Maury, Wendy
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5553159/
https://ncbi.nlm.nih.gov/pubmed/28615211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00479-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars